ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase

February 27, 2004

RFPs Available, NIH Funding Strategies

February 18, 1994

Obituary: I. Bernard Weinstein, 78, Of Columbia Univ.

November 14, 2008

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

Program Announcement For Clinical Research

February 29, 1980